Conflixis offers an AI-powered risk engine that helps organizations identify and manage conflicts of interest and external influence, promoting trust and transparency in decision-making.

Conflixis

Conflixis | 1,637 followers on LinkedIn. Discover conflicts of interest and outside influence in your organization. | The Conflixis risk engine unlocks the power of external data and internal information to promote trust and transparency at large organizations.

Co-Founder & COO

Vincent Wan

Software Engineer – Rallyware

Kateryna Prokofieva

Director @ Conflixis

Jessica Francis

🚀 🕵♂️ Our Inaugural Open Payments Report is finally here! 🕵♂️ 🚀 We invite you to read the Wall Street Journal's exclusive report coverage: https://lnkd.in/eJmX5-wF In this report, we delve into specific examples and critical questions about industry influence today. We demonstrate how regulators, institutions, and others can use this information to promote transparency and ethical practices in healthcare. Our goal is to provide valuable insights for patients, compliance and legal professionals, policymakers, healthcare providers, and researchers. By identifying and managing conflicts of interest, we aim to help mitigate rising costs and ensure better healthcare outcomes. Download the report now and join us in driving forward transparency and trust in healthcare. https://lnkd.in/eq4EbZzt Feel free to reach out or book a meeting with our team if you have any questions or need further insights. #Conflixis #OpenPayments #HealthcareCompliance #ConflictsOfInterest #HealthcareTransparency #EthicalHealthcare #SupplyChainRisk #ThirdPartyRisk

We're #hiring a new Business Development Representative in Dallas, Texas. Apply today or share this post with your network.

We're #hiring a new Healthcare Conflict Data Scientist in Dallas, Texas. Apply today or share this post with your network.

We're #hiring a new Cloud Infrastructure & Security Engineer in Dallas, Texas. Apply today or share this post with your network.

We're #hiring a new Conflict Data Analyst in Dallas, Texas. Apply today or share this post with your network.

🔍 Continuing our spotlight on Research Integrity! 🔍 Researchers were paid $67 million to learn about drug and device company products--while doing research funded by that company. Of the $260 million drug and device companies paid to researchers in 2023, $67 million was for speaking and attendance at events that are not for continuing education. Learning about new products and technologies is critical—but when the integrity of research is at stake, more scrutiny is justified. If you work at a research institution and are curious about how your researchers are interacting with industry, get in touch. We will identify your risky relationships—for free. Book a demo with us: https://lnkd.in/eKT5R_Rf Download the 2024 Open Payments report: https://lnkd.in/eq4EbZzt #ResearchIntegrity #ConflictOfInterest #ScienceTransparency #Conflixis #HCCA #AAMC #COI

For the next two weeks, Conflixis will be doing spotlight posts on Research Integrity 🔍 Our 2024 Open Payments Report identified numerous researchers who received promotional, consulting, or royalty payments from entities that were funding research they were undertaking in the same twelve-month period. In 2023 alone, researchers received $260 million in non-research-related payments from funders also financing their studies. 💰 Since 2016, this figure totals $2.3 billion. 💰 Despite stringent policies at academic research centers, researchers' financial relationships with funders might compromise research integrity. It's crucial to address these conflicts of interest to ensure unbiased scientific findings and maintain public trust in research. Download your copy of the Open Payments Report here: https://lnkd.in/eq4EbZzt #ResearchIntegrity #ConflictOfInterest #ScienceTransparency

Latest study from Dr. Aaron Mitchell. Keep it up!!

Coming soon! The Conflixis Open Payments Report. Stay tuned.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 9, 2024 11:51 AM	f19a75b3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 9, 2024 11:51 AM	73d24297
crunchbase trigger	general	Nov 27, 2024 12:50 PM	fe3d09a3
crunchbase profile	general
li profile	general	Nov 9, 2024 11:51 AM	1d794239
translate crunchbase fundingrounds	general
peers	general	Nov 9, 2024 11:51 AM	ef097182
news basic	general	Nov 9, 2024 11:51 AM	a583caae
bundesanzeiger	filings
financials download nd	financials
private financials	financials

CONF

COM:CONFLIXIS

Conflixis